STDN: $15 to $9.75 to $13.31 — Standard Nuclear IPO

STDN closed at $13.31 on August 17, 2026 — still 11.3% below its $15 IPO price, but up 36.5% from the $9.75 low it hit exactly one week after the July 15 pricing. A round trip this fast, on a stock this new, says as much about how thin the float is as about the company's fundamentals.

Standard Nuclear filed its S-1 on July 7 chasing a $3.55 billion valuation, priced at $15.00 on July 15, and fell to a $9.75 close by July 23 as a downsized offering met a sector-wide nuclear selloff. Then, starting around August 10, five Wall Street banks initiated Buy-rated coverage in the same week, and the stock rallied roughly 62% to $13.31 by August 17. What's happened since the original drop is a case study in how fast sentiment can swing on a name with almost no trading history to anchor it.

What Is Standard Nuclear's Stock Price After the IPO?

Standard Nuclear (NYSE: STDN) closed at $13.31 on August 17, 2026, after touching an intraday high of $13.98. That's down 11.3% from a $15.00 IPO price on July 15, but up 36.5% from the $9.75 close it hit on July 23 — the stock's post-IPO low came a week after that, when it briefly traded near $7.05 before analyst coverage turned the trend. Market cap has recovered from roughly $1.55 billion at the low to about $2.14 billion today, still below the $2.4 billion IPO-day pricing.

Figures blend July-August 2026 trading data from StockTitan, Investing.com, StockAnalysis.com, and BusinessWire IPO pricing announcements. The ~Jul 27-31 low and Jul 19 intraday levels are estimated from reported sector-wide percentage declines; exact closing prints for those sessions were not independently confirmed at publication.

The Standard Nuclear IPO: What Changed Between the S-1 and Pricing

Standard Nuclear's original S-1 filing targeted 18.3 million shares at $18–$21, aiming to raise up to $356 million at a fully diluted valuation near $3.7 billion. By pricing day on July 15, that had shrunk to 10 million shares at a flat $15.00 — a $150 million raise, well under half the original target dollar amount, and a headline valuation of roughly $2.4 billion instead of $3.55 billion.

A downsized, below-range IPO followed by a negative debut is a specific signal: underwriters (BofA Securities and Goldman Sachs led the book) couldn't find enough demand at the original terms and cut both the price and the share count to get the deal done at all. That's a very different setup than the typical hot-IPO pattern where a company prices conservatively to guarantee a first-day pop — but the chart above shows the stock has clawed back most of that gap since, which the next section covers. Track how STDN compares to other 2026 listings on the IPO Tracker.

Why Did Standard Nuclear Stock Drop Since Its IPO?

Three things compounded at once during IPO week. First, the offering itself signaled weak demand before the stock even opened. Second, STDN got caught in a sector-wide nuclear selloff that hit nearly every advanced-reactor and fuel name simultaneously — Oklo fell 15.8% for the week, NuScale dropped 14.6%, and X-energy, Nano Nuclear, and Uranium Energy Corp all lost 8-9% in a single session on July 16 as the VanEck Uranium and Nuclear ETF (NLR) slid 16% for the month. Third, STDN-specific reports of heightened regulatory scrutiny tied to reactor-safety questions added company-level pressure on top of the sector move, with the stock trading down as much as 14% in a single stretch on that news.

STDN's IPO-week decline was more than double the sector average, which tells you the drop wasn't purely macro. A brand-new IPO with $3.36 million in trailing revenue and no public trading history to anchor sentiment gets punished harder in a risk-off week than an established name like Oklo, which at least has years of price discovery and a larger investor base absorbing the selling. The utilities largely sat this out — Constellation Energy fell just 2% and Vistra actually rose 5% over the same stretch. This was a growth-and-story selloff, not a broad energy-sector rotation, and that same thin-float, story-driven dynamic is exactly what fueled the rally back the other way once analysts started covering the stock.

STDN's August Rally: What Changed Since the Post-IPO Low

The reversal started with analyst coverage, not company news. Around August 10, 2026, five banks initiated coverage on Standard Nuclear within days of each other — Goldman Sachs at Buy with an $18 price target, Bank of America at Buy with $15, UBS at Buy with $14, plus William Blair and Barclays also at Buy — and the stock gained roughly 62% over the following week to close at $13.31 on August 17. Seven analysts now cover the name with a consensus "Strong Buy" rating and a $16.29 average 12-month price target, per Investing.com's consensus estimates page.

Two other data points reinforced the move. Standard Nuclear disclosed a $245 million contract backlog — the first hard evidence of order-book demand since the IPO — and added Seth Cohen to its board of directors effective August 12, 2026. SEC Form 4 filings also show insider activity around the same window, though the largest filing is Decisive Point Group LLC converting roughly 17.9 million preferred shares into common stock at the $15.00 IPO price on July 17 — a mechanical conversion tied to the offering, not a signal that insiders were buying on the open market during the selloff. The company has also set its first quarterly report as a public company: Q2 2026 results are due after market close on August 26, 2026, with a call the following morning.

What the headline misses

A 62% one-week rally on a stock with a roughly 10-million-share IPO float is a thin-liquidity move as much as a fundamentals re-rating — the same structural setup (small float, no earnings history, story-driven trading) that made the initial 35% drop overshoot on the way down can just as easily make the rebound overshoot on the way up. None of the five bank initiations came with a published model tying the $14-$18 targets to actual revenue guidance, since Standard Nuclear hadn't reported a full quarter yet when the calls were made. The August 26 earnings report is the first real test of whether the $245 million backlog and analyst optimism hold up against actual numbers, and a miss could unwind a meaningful chunk of this rally the way the debut week unwound the IPO price.

Standard Nuclear Stock: Does the Rally Make the Valuation Math Better?

At the original $3.55 billion IPO target, Standard Nuclear was priced at roughly 1,050x its $3.36 million trailing-twelve-month revenue. At the $1.55 billion post-IPO low, that multiple had compressed to roughly 460x. At today's $2.14 billion market cap, it's back up to roughly 637x TTM revenue — cheaper than the IPO ask, but a meaningfully richer multiple than an investor buying at the July low would have paid, since the rally moved faster than the underlying revenue did.

The balance sheet is the one thing that hasn't changed direction. Standard Nuclear raised $150 million in the IPO and reported roughly $125 million in cash on hand as of late July, against a Q1 2026 operating loss of $8.2 million and a gross loss of $4.4 million on just $593,802 of quarterly revenue. That funds several years of runway without needing to raise again, which matters for a pre-revenue-scale industrial company whose entire thesis depends on SMR developers actually placing large fuel orders over the next 3-5 years rather than the next two quarters — the disclosed $245 million contract backlog is the first sign that's starting to happen, but it's backlog, not booked revenue.

What This Means for the Rest of the 2026 Nuclear IPO Pipeline

Standard Nuclear was supposed to be a proof point for the advanced-nuclear investment thesis translating into public-market appetite. Instead, its debut is a warning shot for the other pre-revenue nuclear and SMR names eyeing 2026-2027 listings: a compelling narrative around AI power demand and DOE policy tailwinds isn't automatically enough to clear a $2-3 billion valuation bar when a company is still reporting single-digit-million-dollar revenue. Underwriters on the next nuclear IPO will likely price more conservatively after watching STDN's book-building process force a near-50% cut to the raise before the stock even traded.

For investors, the more useful read isn't "nuclear is overhyped" — Constellation and Vistra's resilience during the same selloff argues against that — it's that the market is now differentiating sharply between profitable nuclear operators and pre-revenue nuclear-adjacent bets. That distinction didn't really exist six months ago, when nearly every ticker with "nuclear" or "SMR" in its story got bid up together. Compare how other 2026 debuts are trading on the Tech IPO dashboard.

How Standard Nuclear's Debut Compares to Other 2026 IPO Stumbles

STDN isn't the only 2026 listing that priced ambitiously and traded down hard once the story met a public order book. Cerebras (CBRS) fell from a $386 opening peak to under $170 before a further earnings-driven crash, and several AI-adjacent IPOs this year have followed a similar arc: strong pre-IPO narrative, aggressive S-1 valuation target, then a sharp reset once quarterly numbers or sector sentiment force a rerating. What sets Standard Nuclear apart is the speed in both directions — the initial 35% decline happened inside a single week of trading, and the 62% rebound off the low happened inside a single week too, because the offering was already downsized going in and the sector selloff hit before the stock had time to build its own independent trading base.

There's a structural reason volatility keeps running hotter for names like STDN than for Cerebras or an established peer like Oklo: the free float is small (10 million IPO shares, a fraction of the roughly 155-160 million shares outstanding on a fully diluted basis), trading volume is still dominated by short-term traders rather than long-only institutional holders who did diligence on the S-1, and there was no earnings history to anchor a floor price until analyst initiations gave the stock a new reference point in mid-August. That combination — thin float and no earnings anchor — is why STDN can move 35% one way and 62% the other inside a month, independent of whether the underlying TRISO fuel business is sound.

The Bottom Line on Standard Nuclear Stock

The Standard Nuclear IPO went from a $3.55 billion target to a $2.4 billion pricing to a $1.55 billion market cap low in under three weeks, then back up to roughly $2.14 billion by mid-August. The initial drop was a sector-wide nuclear selloff plus a downsized, under-demanded offering. The rebound was analyst-driven — five Buy initiations in one week, plus a $245 million contract backlog that gave the story its first hard number. None of it changes the underlying thesis: if advanced nuclear reactors get built in the US at scale over the next decade, someone has to supply the fuel, and Standard Nuclear remains the only domestic commercial-scale TRISO producer with a signed DOE agreement.

What changed is the price you're paying for that bet, and it's changed twice in a month. At $13.31, the multiple is cheaper than the IPO ask but richer than what an investor who bought at the $9.75 or $7.05 lows paid, and the $125 million cash balance still buys time for the SMR order book to materialize. Whether the rally holds depends on what Standard Nuclear reports on August 26, 2026 — that print, not the analyst targets that preceded it, is the next real test. Track STDN and the rest of the 2026 IPO class on the IPO Tracker.